Pharmaceuticals in North America

November 2025 | 44 pages | ID: P37A49B214AEN
MarketLine

Abstracts

Summary

Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
• The North American pharmaceuticals market recorded revenues of $628.5 billion in 2024, representing a compound annual growth rate (CAGR) of 4.1% between 2019 and 2024.
• The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $106.9 billion, equivalent to 17.0% of the market's overall value.
• The North American pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.1%.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in North America
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
• Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the North America pharmaceuticals market by value in 2024?
• What will be the size of the North America pharmaceuticals market in 2029?
• What factors are affecting the strength of competition in the North America pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in North America's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?

8 COMPANY PROFILES

8.1. Johnson & Johnson
8.2. Merck & Co Inc
8.3. AbbVie Inc
8.4. Pfizer Inc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: North America pharmaceuticals market value: $ million, 2019-24
Table 2: North America pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: North America pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: North America pharmaceuticals market geography segmentation: $ million, 2024
Table 5: North America pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Johnson & Johnson: Key Facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Merck & Co Inc: Key Facts
Table 10: Merck & Co Inc: Annual Financial Ratios
Table 11: Merck & Co Inc: Key Employees
Table 12: AbbVie Inc: Key Facts
Table 13: AbbVie Inc: Annual Financial Ratios
Table 14: AbbVie Inc: Key Employees
Table 15: AbbVie Inc: Key Employees Continued
Table 16: Pfizer Inc: Key Facts
Table 17: Pfizer Inc: Annual Financial Ratios
Table 18: Pfizer Inc: Key Employees
Table 19: Pfizer Inc: Key Employees Continued
Table 20: North America Exchange Rate, 2019-24

List Of Figures

LIST OF FIGURES

Figure 1: North America pharmaceuticals market value: $ million, 2019-24
Figure 2: North America pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: North America pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: North America pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in North America, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in North America, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in North America, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2024